PT  - JOURNAL ARTICLE
AU  - Amjad AlMahameed
AU  - John R. Bartholomew
AU  - Heather L. Gornik
AU  - Mark A. Creager
TI  - Contemporary management of peripheral arterial disease
DP  - 2006 Oct 01
TA  - Cleveland Clinic Journal of Medicine
PG  - S30--S37
VI  - 73
IP  - 10 suppl 4
4099  - http://www.ccjm.org/content/73/10_suppl_4/S30.short
4100  - http://www.ccjm.org/content/73/10_suppl_4/S30.full
SO  - Cleve Clin J Med2006 Oct 01; 73
AB  - Patients with peripheral arterial disease (PAD) are at increased risk of myocardial infarction or stroke, since multiple vascular beds, beyond the extremities, are likely to be affected by atherosclerosis. In addition to management of leg symptoms in patients with PAD, aggressive modification of cardiovascular risk factors is essential. Smoking cessation, antiplatelet medications, statin drugs, and blood pressure control are proven therapies and strategies for prolonging the lives of patients with PAD. Intensive glycemic control in diabetic patients with PAD lowers the risk of microvascular complications, such as nephropathy, and may reduce the risk of major cardiovascular events and lower extremity amputation. Although aggressive cardiovascular risk-factor modification for patients with PAD may be intuitive, these lifesaving medical therapies for PAD are greatly underprescribed.